Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

NCT05916469 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05916469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05916469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Lead sponsor
Oregon Health and Science University
Phase
Observational
Overall status
Recruiting
Start date
September 24, 2025
Completion date
June 30, 2029
Enrollment
300 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding disorder, heavy menstrual bleeding, von willebrand diseases